335 related articles for article (PubMed ID: 21677700)
1. Endothelin: key mediator of hypertension in preeclampsia.
George EM; Granger JP
Am J Hypertens; 2011 Sep; 24(9):964-9. PubMed ID: 21677700
[TBL] [Abstract][Full Text] [Related]
2. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.
Murphy SR; LaMarca BB; Cockrell K; Granger JP
Hypertension; 2010 Feb; 55(2):394-8. PubMed ID: 20026766
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
Possomato-Vieira JS; Khalil RA
Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
[TBL] [Abstract][Full Text] [Related]
6. Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1.
George EM; Granger JP
Hypertension; 2012 Aug; 60(2):507-11. PubMed ID: 22566502
[No Abstract] [Full Text] [Related]
7. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.
Xia Y; Kellems RE
Circ Res; 2013 Jun; 113(1):78-87. PubMed ID: 23788505
[TBL] [Abstract][Full Text] [Related]
8. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.
LaMarca B; Parrish M; Ray LF; Murphy SR; Roberts L; Glover P; Wallukat G; Wenzel K; Cockrell K; Martin JN; Ryan MJ; Dechend R
Hypertension; 2009 Oct; 54(4):905-9. PubMed ID: 19704104
[TBL] [Abstract][Full Text] [Related]
10. Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats.
Zhou J; Xiao D; Hu Y; Wang Z; Paradis A; Mata-Greenwood E; Zhang L
Hypertension; 2013 Sep; 62(3):599-607. PubMed ID: 23817493
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
[TBL] [Abstract][Full Text] [Related]
12. From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia.
Wagner SJ; Craici IM; Grande JP; Garovic VD
Clin Nephrol; 2012 Sep; 78(3):241-9. PubMed ID: 22874114
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.
Zhou CC; Ahmad S; Mi T; Abbasi S; Xia L; Day MC; Ramin SM; Ahmed A; Kellems RE; Xia Y
Hypertension; 2008 Apr; 51(4):1010-9. PubMed ID: 18259044
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
Wang W; Irani RA; Zhang Y; Ramin SM; Blackwell SC; Tao L; Kellems RE; Xia Y
Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.
Saleh L; Verdonk K; Visser W; van den Meiracker AH; Danser AH
Ther Adv Cardiovasc Dis; 2016 Oct; 10(5):282-93. PubMed ID: 26755746
[TBL] [Abstract][Full Text] [Related]
16. The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia.
Campbell N; LaMarca B; Cunningham MW
Curr Pharm Biotechnol; 2018; 19(10):781-785. PubMed ID: 30255752
[TBL] [Abstract][Full Text] [Related]
17. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-independent upregulation of placental hypoxia inducible factor-1α gene expression contributes to the pathogenesis of preeclampsia.
Iriyama T; Wang W; Parchim NF; Song A; Blackwell SC; Sibai BM; Kellems RE; Xia Y
Hypertension; 2015 Jun; 65(6):1307-15. PubMed ID: 25847948
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.
Siddiqui AH; Irani RA; Blackwell SC; Ramin SM; Kellems RE; Xia Y
Hypertension; 2010 Feb; 55(2):386-93. PubMed ID: 19996068
[TBL] [Abstract][Full Text] [Related]
20. Carbon Monoxide Releasing Molecules Blunt Placental Ischemia-Induced Hypertension.
George EM; Cockrell K; Arany M; Stec DE; Rimoldi JM; Gadepalli RSV; Granger JP
Am J Hypertens; 2017 Sep; 30(9):931-937. PubMed ID: 28472389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
